Today’s stock to be analyzed is Cipla Limited.
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India, and founded in 1935 by Khawaja Abdul Hamied. It is a global pharmaceutical company that caters to 80+ markets worldwide by operating 46 manufacturing sites and producing 1500+ pharmaceutical products.
Cipla is well Known for its strength in respiratory, anti-retroviral, urology, cardiology, anti-infective, and CNS as well as other key therapeutic segments. It is the world’s largest manufacturer of antiretroviral drugs. It has over 25000+ employees and a present market capitalization of Rs.61525.71 crores.
During these tough times of Covid-19 Cipla has been at the forefront of Covid care with treatment drugs like Remdesivir, Tocilizumab, and Favipiravir. They have recently also announced the commercialization of a covid-19 testing kit named ELIFast.